Get the Stockscreener App
4.04
0.00%
0.00
X 4 Pharmaceuticals Inc Stock (XFOR) Forecast
The X 4 Pharmaceuticals Inc (XFOR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.21, representing a +4.21% increase from the current price of $4.04. The highest analyst price target is $4.0155, and the lowest is $4.4045.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XFOR Price Target
Average 5.846
(+44.70% Upside)
Is X 4 Pharmaceuticals Inc (XFOR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.87 | Neutral |
| STOCH(9,6) | 24.36 | Neutral |
| STOCHRSI(14) | 54.50 | Neutral |
| MACD(12,26) | -0.0638 | Sell |
| ADX(14) | 17.66 | Neutral |
| William %R | -53.85 | Neutral |
| CCI(14) | -9.85 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.018
Buy
|
3.9924
Buy
|
| MA20 |
4.119
Sell
|
4.0627
Sell
|
| MA50 |
4.1136
Sell
|
4.0494
Sell
|
| MA100 |
3.8991
Buy
|
3.9694
Buy
|
| MA200 |
3.6805
Buy
|
4.4181
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, XFOR could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on XFOR, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.87 indicates that XFOR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.36 indicates that XFOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 54.5 indicates that XFOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.66 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -9.85 indicates that XFOR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term XFOR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about X 4 Pharmaceuticals Inc financial reports and earnings history, X 4 Pharmaceuticals Inc (XFOR) stock could reach $24.79 by 2030, $14.99 by 2040 and $46.52 by 2050. See the projected annual prices until 2050 of the X 4 Pharmaceuticals Inc stock below:
- X 4 Pharmaceuticals Inc (XFOR) is expected to reach an average price of $4.9633 in 2035, with a high prediction of $5.423 and a low estimate of $5.008. This indicates an $22.86% rise from the last recorded price of $4.04.
- X 4 Pharmaceuticals Inc (XFOR) stock is projected to chart a bullish course in 2040, with an average price target of $13.86, representing an $242.99% surge from its current level. The forecast ranges from a conservative $14.14 to a sky-high $14.99.
- Our analysts predict X 4 Pharmaceuticals Inc (XFOR) to jump 565.39% by 2045, soaring from $27.61 to an average price of $26.88, potentially reaching $28.65. While $27.61 is the low estimate, the potential upside is significant.
- X 4 Pharmaceuticals Inc (XFOR) stock is expected to climb by 2050, reaching an average of $45.48, a $1,026% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.52 and $45.51, respectively, highlighting the market's uncertainty.
X 4 Pharmaceuticals Inc Stock (XFOR) Year by Year Forecast
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2026
The predicted value for X 4 Pharmaceuticals Inc (XFOR) in 2026 is set at an average of $5.8235. Estimates vary from a peak of $8.0165 to a trough of $3.6305, indicating an +44.15% surge from the present price of $4.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $4.0145 | $4.4045 | $4.0155 | -0.63% |
| July, 2026 | $5.077 | $4.3035 | $4.2075 | +25.67% |
| August, 2026 | $3.705 | $3.6305 | $4.6215 | -8.29% |
| September, 2026 | $5.7875 | $4.9895 | $5.7375 | +43.25% |
| October, 2026 | $5.7455 | $6.2955 | $6.0165 | +42.22% |
| November, 2026 | $6.4635 | $6.18 | $6.479 | +59.99% |
| December, 2026 | $5.93 | $6.186 | $6.268 | +46.78% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for X 4 Pharmaceuticals Inc (XFOR) is $6.9795, with a high forecast of $8.0695 and a low forecast of $5.8895. This indicates an +72.76% increase from the last price of $4.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.504 | $5.8895 | $5.8705 | +60.99% |
| February, 2027 | $5.962 | $6.042 | $5.8185 | +47.57% |
| March, 2027 | $7.9445 | $6.361 | $7.1845 | +96.65% |
| April, 2027 | $8.0625 | $8.068 | $7.8325 | +99.57% |
| May, 2027 | $8.0405 | $8.036 | $8.0615 | +99.02% |
| June, 2027 | $7.563 | $8.063 | $8.0695 | +87.20% |
| July, 2027 | $7.551 | $7.5475 | $7.302 | +86.91% |
| August, 2027 | $7.739 | $7.4455 | $7.509 | +91.56% |
| September, 2027 | $7.4615 | $7.6415 | $7.6325 | +84.69% |
| October, 2027 | $7.3695 | $7.425 | $7.396 | +82.41% |
| November, 2027 | $7.0675 | $7.2175 | $7.207 | +74.94% |
| December, 2027 | $6.44 | $6.75 | $6.942 | +59.41% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2028
In 2028, X 4 Pharmaceuticals Inc (XFOR) is projected to reach an average price of $4.6092, with a high projection of $6.5935 and a low estimate of $2.625. This indicates an +14.09% rise from the last price of $4.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.568 | $6.648 | $6.5935 | +62.57% |
| February, 2028 | $5.626 | $6.447 | $6.3025 | +39.26% |
| March, 2028 | $5.1085 | $5.1485 | $5.0895 | +26.45% |
| April, 2028 | $4.9465 | $5.0665 | $4.983 | +22.44% |
| May, 2028 | $5.5576 | $5.201 | $5.5492 | +37.56% |
| June, 2028 | $5.067 | $5.137 | $5.3546 | +25.42% |
| July, 2028 | $4.925 | $4.9505 | $4.976 | +21.91% |
| August, 2028 | $4.6823 | $4.721 | $4.8095 | +15.90% |
| September, 2028 | $4.4808 | $4.5045 | $4.552 | +10.91% |
| October, 2028 | $3.3435 | $3.6635 | $3.97 | -17.24% |
| November, 2028 | $2.516 | $2.716 | $3.228 | -37.72% |
| December, 2028 | $2.514 | $2.625 | $2.494 | -37.77% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2029
The 2029 price forecast for X 4 Pharmaceuticals Inc Stock (XFOR) is $9.5867 on average, with a high prediction of $19.13 and a low estimate of $0.0435. This represents an +137.30% increase from the previous price of $4.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.3365 | $2.3965 | $2.3785 | -42.17% |
| February, 2029 | $2.5645 | $2.381 | $2.545 | -36.52% |
| March, 2029 | $2.4925 | $2.458 | $2.459 | -38.31% |
| April, 2029 | $2.4491 | $2.4615 | $2.407 | -39.38% |
| May, 2029 | $2.2627 | $2.311 | $2.3426 | -43.99% |
| June, 2029 | $2.011 | $2.05 | $2.1075 | -50.22% |
| July, 2029 | $1.6505 | $1.7656 | $1.8712 | -59.15% |
| August, 2029 | $1.3801 | $1.4232 | $1.508 | -65.84% |
| September, 2029 | $0.962 | $1.0595 | $1.2261 | -76.19% |
| October, 2029 | $0.112 | $0.677 | $0.804 | -97.23% |
| November, 2029 | $0.05 | $0.111 | $0.159 | -98.76% |
| December, 2029 | $19.20 | $0.0435 | $19.13 | +375.25% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2030
X 4 Pharmaceuticals Inc Stock (XFOR) is expected to reach an average price of $25.24 in 2030, with a high forecast of $26.71 and a low forecast of $23.77. This signifies an +524.70% surge from the last price of $4.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $25.35 | $23.84 | $24.79 | +527.60% |
| February, 2030 | $24.80 | $24.76 | $24.27 | +513.89% |
| March, 2030 | $27.80 | $25.81 | $26.71 | +588.04% |
| April, 2030 | $25.84 | $25.98 | $26.39 | +539.55% |
| May, 2030 | $25.13 | $24.62 | $24.65 | +521.98% |
| June, 2030 | $25.14 | $25.34 | $25.07 | +522.25% |
| July, 2030 | $23.05 | $23.77 | $24.47 | +470.52% |
| August, 2030 | $25.48 | $25.53 | $24.95 | +530.82% |
| September, 2030 | $24.60 | $24.95 | $24.60 | +508.94% |
| October, 2030 | $25.65 | $25.60 | $25.79 | +534.93% |
| November, 2030 | $26.61 | $24.76 | $24.49 | +558.71% |
| December, 2030 | $25.14 | $25.79 | $25.06 | +522.23% |
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):